Xue HY - Search Results

1

Lipid nanocarrier targeting activated macrophages for antiretroviral therapy of HIV reservoir.

Wu D, Si M, Xue HY, Tran NT, Khalili K, Kaminski R, Wong HL. Wu D, et al. Among authors: xue hy. Nanomedicine (Lond). 2023 Aug;18(20):1343-1360. doi: 10.2217/nnm-2023-0120. Epub 2023 Oct 10. Nanomedicine (Lond). 2023. PMID: 37815117 Free PMC article.

2

Tailoring nanostructured solid-lipid carriers for time-controlled intracellular siRNA kinetics to sustain RNAi-mediated chemosensitization.

Xue HY, Wong HL. Xue HY, et al. Biomaterials. 2011 Apr;32(10):2662-72. doi: 10.1016/j.biomaterials.2010.12.029. Epub 2011 Jan 14. Biomaterials. 2011. PMID: 21236485

3

Targeting megalin to enhance delivery of anti-clusterin small-interfering RNA nanomedicine to chemo-treated breast cancer.

Xue HY, Wong HL. Xue HY, et al. Eur J Pharm Biopharm. 2012 May;81(1):24-32. doi: 10.1016/j.ejpb.2012.02.005. Epub 2012 Feb 18. Eur J Pharm Biopharm. 2012. PMID: 22369881

4

Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine.

Xue HY, Liu S, Wong HL. Xue HY, et al. Nanomedicine (Lond). 2014 Feb;9(2):295-312. doi: 10.2217/nnm.13.204. Nanomedicine (Lond). 2014. PMID: 24552562 Free PMC article. Review.

5

A biodistribution study of solid lipid-polyethyleneimine hybrid nanocarrier for cancer RNAi therapy.

Xue HY, Tran N, Wong HL. Xue HY, et al. Eur J Pharm Biopharm. 2016 Nov;108:68-75. doi: 10.1016/j.ejpb.2016.08.014. Epub 2016 Aug 26. Eur J Pharm Biopharm. 2016. PMID: 27569032 Free PMC article.

6

Nanomedicine applications in the treatment of breast cancer: current state of the art.

Wu D, Si M, Xue HY, Wong HL. Wu D, et al. Among authors: xue hy. Int J Nanomedicine. 2017 Aug 16;12:5879-5892. doi: 10.2147/IJN.S123437. eCollection 2017. Int J Nanomedicine. 2017. PMID: 28860754 Free PMC article. Review.

7

Lipid-polymer hybrid nanoparticles carrying linezolid improve treatment of methicillin-resistant Staphylococcus aureus (MRSA) harbored inside bone cells and biofilms.

Guo P, Buttaro BA, Xue HY, Tran NT, Wong HL. Guo P, et al. Among authors: xue hy. Eur J Pharm Biopharm. 2020 Jun;151:189-198. doi: 10.1016/j.ejpb.2020.04.010. Epub 2020 Apr 23. Eur J Pharm Biopharm. 2020. PMID: 32335285 Free PMC article.

8

Enhanced eradication of intracellular and biofilm-residing methicillin-resistant Staphylococcus aureus (MRSA) reservoirs with hybrid nanoparticles delivering rifampicin.

Guo P, Xue HY, Buttaro BA, Tran NT, Wong HL. Guo P, et al. Among authors: xue hy. Int J Pharm. 2020 Nov 15;589:119784. doi: 10.1016/j.ijpharm.2020.119784. Epub 2020 Aug 30. Int J Pharm. 2020. PMID: 32877731 Free PMC article.

9

Incorporation of docosahexaenoic acid (DHA) enhances nanodelivery of antiretroviral across the blood-brain barrier for treatment of HIV reservoir in brain.

Guo P, Si M, Wu D, Xue HY, Hu W, Wong HL. Guo P, et al. Among authors: xue hy. J Control Release. 2020 Dec 10;328:696-709. doi: 10.1016/j.jconrel.2020.09.050. Epub 2020 Oct 1. J Control Release. 2020. PMID: 33010335 Free PMC article.

10

Nanocarrier for poorly water-soluble anticancer drugs--barriers of translation and solutions.

Narvekar M, Xue HY, Eoh JY, Wong HL. Narvekar M, et al. Among authors: xue hy. AAPS PharmSciTech. 2014 Aug;15(4):822-33. doi: 10.1208/s12249-014-0107-x. Epub 2014 Apr 2. AAPS PharmSciTech. 2014. PMID: 24687241 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters